130 related articles for article (PubMed ID: 6613469)
1. Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.
Magnusson KE; Sundqvist T; Sjödahl R; Tagesson C
Acta Chir Scand; 1983; 149(3):323-7. PubMed ID: 6613469
[TBL] [Abstract][Full Text] [Related]
2. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
Heuman R; Sjödahl R; Tagesson C
Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
[TBL] [Abstract][Full Text] [Related]
3. Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality.
Olaison G; Sjödahl R; Tagesson C
Acta Chir Scand; 1987; 153(5-6):373-7. PubMed ID: 3661039
[TBL] [Abstract][Full Text] [Related]
4. Reduced intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with jejunoileal bypass.
Sundqvist T; Magnusson KE; Larsson L; Tagesson C; Backman L; Nordenvall B
Acta Chir Scand; 1984; 150(7):567-71. PubMed ID: 6516679
[TBL] [Abstract][Full Text] [Related]
5. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of vitamin A therapy in severe Crohn's disease.
Norrby S; Sjödahl R; Tagesson C
Acta Chir Scand; 1985; 151(5):465-8. PubMed ID: 3901639
[TBL] [Abstract][Full Text] [Related]
7. Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.
Olaison G; Leandersson P; Sjödahl R; Tagesson C
Gut; 1988 Feb; 29(2):196-9. PubMed ID: 3345930
[TBL] [Abstract][Full Text] [Related]
8. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
[TBL] [Abstract][Full Text] [Related]
9. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400.
Chadwick VS; Phillips SF; Hofmann AF
Gastroenterology; 1977 Aug; 73(2):241-6. PubMed ID: 873124
[TBL] [Abstract][Full Text] [Related]
10. Increased gastric and intestinal permeability in patients with Crohn's disease.
Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
[TBL] [Abstract][Full Text] [Related]
11. Abnormal intestinal permeability pattern in colonic Crohn's disease. Absorption of low molecular weight polyethylene glycols after oral or colonic load.
Olaison G; Sjödahl R; Leandersson P; Tagesson C
Scand J Gastroenterol; 1989 Jun; 24(5):571-6. PubMed ID: 2762756
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after intestinal resection for Crohn's disease.
Landsend E; Johnson E; Johannessen HO; Carlsen E
Scand J Gastroenterol; 2006 Oct; 41(10):1204-8. PubMed ID: 16990206
[TBL] [Abstract][Full Text] [Related]
13. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
[TBL] [Abstract][Full Text] [Related]
14. Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery.
Behrend C; Jeppesen PB; Mortensen PB
Eur J Gastroenterol Hepatol; 1995 May; 7(5):397-400. PubMed ID: 7614100
[TBL] [Abstract][Full Text] [Related]
15. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
Sandborn WJ; Tremaine WJ; Lawson GM
Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
[TBL] [Abstract][Full Text] [Related]
17. Intestinal permeability to different-sized polyethyleneglycols in patients with rheumatoid arthritis.
Tagesson C; Bengtsson A
Scand J Rheumatol; 1983; 12(2):124-8. PubMed ID: 6857170
[TBL] [Abstract][Full Text] [Related]
18. Modelling of intestinal permeability in man to polyethylene glycols (PEG 400 and PEG 1000).
Sundqvist T; Magnusson KE
Acta Physiol Scand; 1985 Oct; 125(2):289-96. PubMed ID: 4072712
[TBL] [Abstract][Full Text] [Related]
19. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission.
Vaisman N; Dotan I; Halack A; Niv E
Nutrition; 2006 Sep; 22(9):855-9. PubMed ID: 16928471
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G subclasses in Crohn's disease with and without bowel resection.
Bures J; Tichý M; Horácek J; Král B; Sobotka L; Cervenka B; Zadák Z; Komárková O; Fixa B; Pidrman V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):139-47. PubMed ID: 8159910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
